106 related articles for article (PubMed ID: 2495256)
1. Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameters in body builders.
Zuliani U; Bernardini B; Catapano A; Campana M; Cerioli G; Spattini M
Int J Sports Med; 1989 Feb; 10(1):62-6. PubMed ID: 2495256
[TBL] [Abstract][Full Text] [Related]
2. Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids.
Webb OL; Laskarzewski PM; Glueck CJ
Metabolism; 1984 Nov; 33(11):971-5. PubMed ID: 6493049
[TBL] [Abstract][Full Text] [Related]
3. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.
Dickerman RD; McConathy WJ; Zachariah NY
J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668
[TBL] [Abstract][Full Text] [Related]
4. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
5. Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders.
Kuipers H; Wijnen JA; Hartgens F; Willems SM
Int J Sports Med; 1991 Aug; 12(4):413-8. PubMed ID: 1917227
[TBL] [Abstract][Full Text] [Related]
6. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes.
Hartgens F; Cheriex EC; Kuipers H
Int J Sports Med; 2003 Jul; 24(5):344-51. PubMed ID: 12868045
[TBL] [Abstract][Full Text] [Related]
7. Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders.
Lenders JW; Demacker PN; Vos JA; Jansen PL; Hoitsma AJ; van 't Laar A; Thien T
Int J Sports Med; 1988 Feb; 9(1):19-23. PubMed ID: 3366514
[TBL] [Abstract][Full Text] [Related]
8. Testosterone enanthate at a dose of 200 mg/week decreases HDL-cholesterol levels in healthy men.
Meriggiola MC; Marcovina S; Paulsen CA; Bremner WJ
Int J Androl; 1995 Oct; 18(5):237-42. PubMed ID: 8567093
[TBL] [Abstract][Full Text] [Related]
9. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA
J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
[TBL] [Abstract][Full Text] [Related]
10. Lipid profile of body builders with and without self-administration of anabolic steroids.
Fröhlich J; Kullmer T; Urhausen A; Bergmann R; Kindermann W
Eur J Appl Physiol Occup Physiol; 1989; 59(1-2):98-103. PubMed ID: 2583156
[TBL] [Abstract][Full Text] [Related]
11. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular dimensions and function in strength athletes. Re: Hartgens F, Cheriex EC, Kuipers H. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes. Int J Sports Med 2003; 24: 344 - 351.
Kindermann W; Urhausen A
Int J Sports Med; 2004 Apr; 25(3):241-2; author reply 243-4. PubMed ID: 15088251
[No Abstract] [Full Text] [Related]
13. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
[TBL] [Abstract][Full Text] [Related]
14. Serum lipids in power athletes self-administering testosterone and anabolic steroids.
Alén M; Rahkila P; Marniemi J
Int J Sports Med; 1985 Jun; 6(3):139-44. PubMed ID: 4030188
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipids and apolipoproteins A and B in human pregnancy.
Pocoví M; Ordovás JM; Grande-Covián F
Rev Esp Fisiol; 1984 Jun; 40(2):183-9. PubMed ID: 6333054
[TBL] [Abstract][Full Text] [Related]
16. Evolution of serum lipids in two male bodybuilders using anabolic steroids.
Lajarin F; Zaragoza R; Tovar I; Martinez-Hernandez P
Clin Chem; 1996 Jun; 42(6 Pt 1):970-2. PubMed ID: 8665691
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
18. Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B.
Castelo-Branco C; Casals E; Figueras F; Sanjuan A; Vicente JJ; Balasch J; Vanrell JA
Menopause; 1999; 6(2):92-7. PubMed ID: 10374214
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular size and function in body builders using anabolic steroids.
Salke RC; Rowland TW; Burke EJ
Med Sci Sports Exerc; 1985 Dec; 17(6):701-4. PubMed ID: 4079743
[TBL] [Abstract][Full Text] [Related]
20. Effect of androgenic and anabolic steroids on the sebaceous gland in power athletes.
Király CL; Alén M; Rahkila P; Horsmanheimo M
Acta Derm Venereol; 1987; 67(1):36-40. PubMed ID: 2436412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
